Oncology Postdoc: Target Discovery for Precision Medicines

Orion Pharma; Turku; On-site; EUR 42,000 - 64,000; Full time

Benefits offered by this job

Two-year project

State-of-the-art facilities

International collaboration

Publication support

Job summary

Orion Pharma in Finland seeks a Postdoctoral Researcher to bridge academic research and industrial innovation. You will lead a standalone project identifying novel targets and validating strategies for induced proximity medicines in oncology, working with Orion scientists and external academic partners.

The two-year program emphasizes high-quality publications, collaboration, and translating findings into industry-relevant outcomes while ensuring quality and IP compliance.

Qualifications

• PhD in a relevant scientific discipline.
• Strong scientific publication record relative to career stage.
• Excellent written and verbal communication skills in English.
• Ability to work both independently and collaboratively in multidisciplinary environments.

Responsibilities

• Lead and execute an independent postdoctoral research project.
• Design, conduct, analyse, and interpret scientific studies.
• Develop innovative solutions to research questions relevant to the pharmaceutical industry.
• Collaborate effectively with cross-functional teams within Orion and external academic partners.
• Prepare high-quality scientific reports, publications, presentations, and project updates.
• Present research findings to internal and external stakeholders.
• Contribute to scientific discussions, innovation activities, and knowledge sharing.
• Ensure compliance with applicable quality, safety, data integrity, and intellectual property requirements.

Skills

Scientific publications

English communication

Independent work

Collaborative

Education

PhD in a relevant scientific discipline

Job description

Orion Pharma in Finland seeks a Postdoctoral Researcher to bridge academic research and industrial innovation. You will lead a standalone project identifying novel targets and validating strategies for induced proximity medicines in oncology, working with Orion scientists and external academic partners.

The two-year program emphasizes high-quality publications, collaboration, and translating findings into industry-relevant outcomes while ensuring quality and IP compliance.